Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
238
NCT00891137
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2009
Completion: Jun 30, 2014
NCT01297543
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia
Phase: Phase 1/2
Start: Mar 31, 2011
Completion: Jan 31, 2015
NCT02282215
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Phase: Phase 2
Start: Dec 31, 2014
Completion: Sep 22, 2017